Figure 1.The result of AS treatment. (A–C) Peripheral blood cell counts in different groups. (D) IL17A protein level in different groups. (E) IL17A mRNA level in different groups. (F) Transfusion dependency risk in different groups. (G) Hazard ratio of different characters in aplastic anemia patients.
